DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
MEM 3454
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MEM 3454
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFACIFENACIN
2
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder, Overactive
Muscarinic acetylcholine receptor antagonist
AFACIFENACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XQU62QZ74P
Molecule Type:
Small molecule
Molecular Formula:
C27H26F3N3O2
Molecular Weight:
481.52
AlogP:
6.19
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FIACITABINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FIACITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4058H365ZB
Molecule Type:
Small molecule
Molecular Formula:
C9H11FIN3O4
Molecular Weight:
371.11
AlogP:
-0.98
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
S-ADENOSYL-L-METHIONINE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Tobacco Use Disorder
Unknown
S-ADENOSYL-L-METHIONINE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H22N6O5S
Molecular Weight:
398.45
AlogP:
-3.26
PSA:
185.46
HBD:
4.0
HBA:
#RotB:
7.0
Source:
VATIQUINONE
2
Small molecule
Investigational
Unknown
Unknown
Muscular Diseases; Tourette Syndrome; Child Development Disorders, Pervasive; Friedreich Ataxia; Hearing Loss, Noise-Induced; Leigh Disease; Mitochondrial Diseases; Parkinson Disease; Rett Syndrome
Quinone reductase 1) modulator
VATIQUINONE
×
Maximum Phase:
2
First Approval:
None
UNII:
6O85FK9I0X
Molecule Type:
Small molecule
Molecular Formula:
C29H44O3
Molecular Weight:
440.67
AlogP:
7.52
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
12.0
Source:
NEFIRACETAM
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
NEFIRACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
1JK12GX30N
Molecule Type:
Small molecule
Molecular Formula:
C14H18N2O2
Molecular Weight:
246.31
AlogP:
1.86
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SSR180711
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist
SSR180711
×
Maximum Phase:
2
First Approval:
None
UNII:
QF4P1U1666
Molecule Type:
Small molecule
Molecular Formula:
C14H17BrN2O2
Molecular Weight:
325.21
AlogP:
2.73
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
1.0
Source:
RO4998452
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RO4998452
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-817399
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
C-C chemokine receptor type 1 antagonist
BMS-817399
×
Maximum Phase:
2
First Approval:
None
UNII:
AKQ3X6FEH0
Molecule Type:
Small molecule
Molecular Formula:
C23H36ClN3O4
Molecular Weight:
454.01
AlogP:
2.88
PSA:
101.9
HBD:
4.0
HBA:
#RotB:
6.0
Source:
COFORMYCIN
2
Small molecule
Investigational
Unknown
Unknown
Leukemia
Adenosine deaminase inhibitor
COFORMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
E49510ZL0H
Molecule Type:
Small molecule
Molecular Formula:
C11H16N4O5
Molecular Weight:
284.27
AlogP:
-2.21
PSA:
132.36
HBD:
5.0
HBA:
#RotB:
2.0
Source:
ELZASONAN
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
ELZASONAN
×
Maximum Phase:
2
First Approval:
None
UNII:
933PJL964R
Molecule Type:
Small molecule
Molecular Formula:
C22H23Cl2N3OS
Molecular Weight:
448.42
AlogP:
4.87
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
VAPENDAVIR
2
Small molecule
Investigational
Unknown
Unknown
Asthma
VP1 capsid protein inhibitor
VAPENDAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
Q8LVL5Z68H
Molecule Type:
Small molecule
Molecular Formula:
C21H26N4O3
Molecular Weight:
382.46
AlogP:
4.01
PSA:
73.51
HBD:
0.0
HBA:
#RotB:
7.0
Source:
CXA-10
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury; Asthma; Glomerulosclerosis, Focal Segmental; Hypertension, Pulmonary
Unknown
CXA-10
×
Maximum Phase:
2
First Approval:
None
UNII:
1N19AGY57Y
Molecule Type:
Small molecule
Molecular Formula:
C18H33NO4
Molecular Weight:
327.46
AlogP:
5.71
PSA:
80.44
HBD:
1.0
HBA:
#RotB:
16.0
Source:
TENATOPRAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Esophagitis, Peptic
Unknown
TENATOPRAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
RE0689TX2K
Molecule Type:
Small molecule
Molecular Formula:
C16H18N4O3S
Molecular Weight:
346.41
AlogP:
2.29
PSA:
89.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MOSEDIPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Neutropenia; Severe Acute Respiratory Syndrome; Stomatitis
Unknown
MOSEDIPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
88928BS57E
Molecule Type:
Small molecule
Molecular Formula:
C39H70O6
Molecular Weight:
634.98
AlogP:
11.3
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
33.0
Source:
BI-671800
2
Small molecule
Investigational
Unknown
Unknown
Asthma
G protein-coupled receptor 44 antagonist
BI-671800
×
Maximum Phase:
2
First Approval:
None
UNII:
721F767LHB
Molecule Type:
Small molecule
Molecular Formula:
C25H26F3N5O3
Molecular Weight:
501.51
AlogP:
4.1
PSA:
98.66
HBD:
2.0
HBA:
#RotB:
8.0
Source:
LCB01-0371
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LCB01-0371
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IVA337
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IVA337
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALAMPANEL
2
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Astrocytoma; Central Nervous System Neoplasms; Epilepsy; Glioblastoma; Oligodendroglioma; Parkinson Disease
Glutamate receptor ionotropic, AMPA 1 antagonist
TALAMPANEL
×
Maximum Phase:
2
First Approval:
None
UNII:
CVS43XG1L5
Molecule Type:
Small molecule
Molecular Formula:
C19H19N3O3
Molecular Weight:
337.38
AlogP:
2.54
PSA:
77.15
HBD:
1.0
HBA:
#RotB:
1.0
Source:
VIDOFLUDIMUS
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Cholangitis, Sclerosing; Colitis, Ulcerative; Inflammatory Bowel Diseases; Multiple Sclerosis; Severe Acute Respiratory Syndrome
Dihydroorotate dehydrogenase inhibitor
VIDOFLUDIMUS
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y1PJ3VG81
Molecule Type:
Small molecule
Molecular Formula:
C20H18FNO4
Molecular Weight:
355.37
AlogP:
4.0
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
5.0
Source:
IMARADENANT
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Adenosine A2a receptor antagonist
IMARADENANT
×
Maximum Phase:
2
First Approval:
None
UNII:
770140J08A
Molecule Type:
Small molecule
Molecular Formula:
C15H11ClFN5
Molecular Weight:
315.74
AlogP:
3.28
PSA:
77.58
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SPH-3127
2
Small molecule
Investigational
Unknown
Unknown
Hypertension
Unknown
SPH-3127
×
Maximum Phase:
2
First Approval:
None
UNII:
C2M78A9V6Z
Molecule Type:
Small molecule
Molecular Formula:
C22H32N6O4
Molecular Weight:
444.54
AlogP:
1.53
PSA:
110.61
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IPI-549
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IPI-549
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALDARET MONOHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure; Myocardial Infarction
Unknown
CALDARET MONOHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
2SH110E854
Molecule Type:
Small molecule
Molecular Formula:
C11H18N2O4S
Molecular Weight:
274.34
AlogP:
0.65
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PF-03635659
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
PF-03635659
×
Maximum Phase:
2
First Approval:
None
UNII:
O0RG3QM34H
Molecule Type:
Small molecule
Molecular Formula:
C28H32N2O3
Molecular Weight:
444.58
AlogP:
4.49
PSA:
75.79
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ALFLUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
ALFLUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
A49A7A5YN4
Molecule Type:
Small molecule
Molecular Formula:
C28H31F3N8O2
Molecular Weight:
568.6
AlogP:
4.84
PSA:
100.44
HBD:
2.0
HBA:
#RotB:
11.0
Source:
TEBANICLINE TOSYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor; alpha4/beta2 agonist
TEBANICLINE TOSYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
CP1A26546Z
Molecule Type:
Small molecule
Molecular Formula:
C16H19ClN2O4S
Molecular Weight:
370.86
AlogP:
1.48
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
S-777469
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Cannabinoid CB2 receptor agonist
S-777469
×
Maximum Phase:
2
First Approval:
None
UNII:
88NI79737I
Molecule Type:
Small molecule
Molecular Formula:
C23H27FN2O4
Molecular Weight:
414.48
AlogP:
3.42
PSA:
88.4
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NEVANIMIBE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor
NEVANIMIBE
×
Maximum Phase:
2
First Approval:
None
UNII:
VK9OS8R205
Molecule Type:
Small molecule
Molecular Formula:
C27H39N3O
Molecular Weight:
421.63
AlogP:
6.63
PSA:
44.37
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PERFLUORO TERT-BUTYLCYCLOHEXANE
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries
Unknown
PERFLUORO TERT-BUTYLCYCLOHEXANE
×
Maximum Phase:
2
First Approval:
None
UNII:
3ZX1Z33VUU
Molecule Type:
Small molecule
Molecular Formula:
C10F20
Molecular Weight:
500.07
AlogP:
6.56
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
SELONSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Hepatitis, Alcoholic; Hypertension, Pulmonary
Mitogen-activated protein kinase kinase kinase 5 inhibitor
SELONSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
NS3988A2TC
Molecule Type:
Small molecule
Molecular Formula:
C24H24FN7O
Molecular Weight:
445.5
AlogP:
4.68
PSA:
90.52
HBD:
1.0
HBA:
#RotB:
6.0
Source:
2-IMINOBIOTIN
2
Small molecule
Investigational
Unknown
Unknown
Hypoxia-Ischemia, Brain
Unknown
2-IMINOBIOTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
HXH71NRQ5C
Molecule Type:
Small molecule
Molecular Formula:
C10H17N3O2S
Molecular Weight:
243.33
AlogP:
0.61
PSA:
85.21
HBD:
4.0
HBA:
#RotB:
5.0
Source:
X-82
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma; Neoplasms; Pancreatic Neoplasms; Macular Degeneration
Platelet-derived growth factor receptor inhibitor
X-82
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEBOGLAMINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate [NMDA] receptor positive allosteric modulator
NEBOGLAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
12EA34U5B8
Molecule Type:
Small molecule
Molecular Formula:
C13H24N2O3
Molecular Weight:
256.35
AlogP:
1.26
PSA:
92.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TARLOXOTINIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor inhibitor
TARLOXOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
H8768UL06V
Molecule Type:
Small molecule
Molecular Formula:
C24H24BrClN9O3+
Molecular Weight:
601.87
AlogP:
4.6
PSA:
140.76
HBD:
2.0
HBA:
#RotB:
9.0
Source:
1
2
…
110
111
112
113
114
115
116
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA